Illumina collaborated on a study presented at ASCO 2025 showing that circulating tumor DNA provides actionable data for clinical trials
Illumina bioinformatics solutions prove essential for a Northern Territory genomics program
At ESHG 2025 in Milan, Illumina welcomed customers and industry colleagues to discuss the future of genomic research and health care
NYU Langone Director of Molecular Pathology Matija Snuderl says every brain cancer journey should begin with DNA methylation profiling
At the San Diego headquarters, participants took a break from work to connect and create art
| Date | Publication | Title |
|---|---|---|
| May 28, 2025 | CAP Today | NGS and the cancer biomarker balancing act |
| May 21, 2025 | GenomeWeb | Not Just for Kids Anymore: Diagnostic Whole-Genome Sequencing Reaches Adults |
| May 14, 2025 | BioSpectrum | Illumina unveils DRAGEN version 4.4 software focusing on oncology applications for clinical research |
| May 6, 2025 | Bio-IT World | Illumina, Ovation Release GLP-1 Patient Dataset |
| May 1, 2025 | GenomeWeb | Illumina, Ovation.io Partner on Multiomics Analysis of Patients Treated With GLP-1 Therapies |
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsIf you are a member of the media:
If you are not a member of the media, please visit Contact Us.